Research ID
hum0512-v1Release info
Research title
Identification and functional analysis of risk polymorphisms in autoimmune diseases
Research overview
- Aims
- Autoimmune diseases occur when the immune system damages the body's tissues, affecting over 1% of the population. Genomic polymorphisms strongly influence autoimmune disease risk, with many identified through large-scale genomic analyses. Since these risk polymorphisms often cluster in gene expression regulatory regions of immune cells, evaluating their relationship with gene regulation in these cells is essential for understanding their functions. This research aims to elucidate risk polymorphism functions using both natural polymorphisms and artificial ones introduced through genome editing. We will analyze multi-omics data from various cells and employ comprehensive genomic analysis to precisely identify risk polymorphism locations and understand their functions.
- Methods
- bulk RNA-seq, bulk ATAC-seq, single cell CITE-seq (RNA-seq)
- Participants/materials
- 3 healthy donors
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000960 | bulk RNA-seq / bulk ATAC-seq / scCITE-seq of CD4+ / CD3+ T cells from 3 healthy donors following LEF1 siRNA knockdown. |
| Controlled-access (Type I) | 2025-07-31 |
Data provider
- Principal investigator
- Kazuyoshi Ishigaki
- Affiliation
- Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (B) | Establishment of personalized anti-cytokine therapy through functional analysis of autoimmune disease risk polymorphisms |
|
KAKENHI Grant-in-Aid for Research Activity Start-up | Identification of transcription factor controlling autoimmunity risk allele's pathogenic function |
|
KAKENHI Grant-in-Aid for Early-Career Scientists | Functional analysis of rheumatoid arthritis risk polymorphisms using genome editing technology and targeted analysis |
|
Biobank - Construction and Utilization biobank for genomic medicine REalization (B-Cure), Japan Agency for Medical Research and Development (AMED) | Development of technology for evaluating the impact of polygenic risk scores on biological systems |
|
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED) | Elucidation of rheumatoid arthritis pathogenesis through functional analysis of risk polymorphisms combined with genome editing technology |
|
Research and Development Program for Translating Genomic Research into Drug Discovery and Other Applications, Japan Agency for Medical Research and Development (AMED) | Identification of novel diagnostic markers for rheumatoid arthritis based on T cell receptor sequence information using biobanks |
|
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED) | Comprehensive elucidation of T cell-level immune tolerance breakdown through interaction between HLA gene polymorphisms and smoking in rheumatoid arthritis |
|
Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS), Japan Agency for Medical Research and Development (AMED) | Support for large-scale functional genomics analysis using biological samples and advancement of human immune function evaluation platform |
|
Japan Initiative for World-leading Vaccine Research and Development Centers, Japan Agency for Medical Research and Development (AMED) | Support organization for establishment and implementation of human immune evaluation methods centered on multi-omics of genetic diversity and function |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Accurate, sensitive, and efficient chromatin accessibility quantification at target loci using UNIChro-seq |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 |